Eiger Biopharmaceuticals, Inc.
EIGRCIK 0001305253 · Every Form 4 filed by insiders at this issuer. See financials →
Annual report (10-K)
Latest 10-K/A filed Apr 29, 2024. Sentiment + YoY language diff vs prior year. Read sections →
Signal:NeutralFull-doc fallback
Full filing:tone 0.0000
Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.
Recent 8-K announcements
Per-item disclosure feed. Item 2.02 is the earnings release.
Top insiders
Most active reporters at Eiger Biopharmaceuticals, Inc.
| Name | Roles | Filings |
|---|---|---|
| Glenn Jeffrey S | Director | 2 |
| Loh Evan | Director | 2 |
| Ryali Sriram | Officer | 2 |
| Sablich Kim | Director | 2 |
| Sachdev Amit | Director | 2 |
All filings
33 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|